PAR 0.00% 22.0¢ paradigm biopharmaceuticals limited..

Ann: Trading Halt, page-78

  1. 9,814 Posts.
    lightbulb Created with Sketch. 1249
    You have a valid point. Ground breaking from the perspective doctors may be able to provide a viable and effective alternative to their patients with chronic pain with likely multiple comorbidities from lack of function and movement. The current standard of care involves telling your patient to somehow ignore their pain and use pain killers sparingly whilst also maintaining regular unsupervised exercise. Massive gap in patient outcomes to the medical professions expectations through this recommended but outdated regime.

    Put to one side the gamification of the share market, tomorrow is a big day for PAR. I'll continue to highlight DMOAD labelling may not immediately matter given the lack of effective and viable alternatives. Indeed, I'd be staggered if we make it all the way to NDA before we're taken out.


    Last edited by Denial: 03/04/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
0.000(0.00%)
Mkt cap ! $76.95M
Open High Low Value Volume
22.0¢ 23.5¢ 22.0¢ $66.95K 294.6K

Buyers (Bids)

No. Vol. Price($)
8 90092 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 25858 1
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.